Expedia Group Valuation
Is EXPE * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EXPE * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EXPE * (MX$3237) is trading below our estimate of fair value (MX$5532.63)
Significantly Below Fair Value: EXPE * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EXPE *?
Other financial metrics that can be useful for relative valuation.
What is EXPE *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$20.78b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.6x |
Enterprise Value/EBITDA | 12.2x |
PEG Ratio | 1.5x |
Price to Earnings Ratio vs Peers
How does EXPE *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 43x | ||
RLH A RLH Properties. de | 30.9x | n/a | Mex$18.4b |
POSADAS A Grupo Posadas. de | 88.7x | n/a | Mex$13.5b |
HOTEL * Grupo Hotelero Santa Fe. de | 31.2x | 32.6% | Mex$2.6b |
HCITY * Hoteles City Express. de | 21.3x | 45.5% | Mex$2.2b |
EXPE * Expedia Group | 25.7x | 17.0% | Mex$20.8b |
Price-To-Earnings vs Peers: EXPE * is good value based on its Price-To-Earnings Ratio (25.7x) compared to the peer average (43x).
Price to Earnings Ratio vs Industry
How does EXPE *'s PE Ratio compare vs other companies in the South American Hospitality Industry?
Price-To-Earnings vs Industry: EXPE * is expensive based on its Price-To-Earnings Ratio (25.7x) compared to the South American Hospitality industry average (20.3x).
Price to Earnings Ratio vs Fair Ratio
What is EXPE *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 25.7x |
Fair PE Ratio | 25.1x |
Price-To-Earnings vs Fair Ratio: EXPE * is expensive based on its Price-To-Earnings Ratio (25.7x) compared to the estimated Fair Price-To-Earnings Ratio (25.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$3,237.00 | Mex$3,024.00 -6.6% | 13.7% | Mex$3,976.40 | Mex$2,346.08 | n/a | 32 |
Oct ’25 | Mex$2,879.00 | Mex$2,950.66 +2.5% | 14.0% | Mex$3,940.48 | Mex$2,324.88 | n/a | 33 |
Sep ’25 | Mex$2,737.20 | Mex$2,880.56 +5.2% | 14.2% | Mex$3,866.42 | Mex$2,281.19 | n/a | 31 |
Aug ’25 | Mex$2,273.00 | Mex$2,763.62 +21.6% | 14.3% | Mex$3,750.24 | Mex$2,212.64 | n/a | 31 |
Jul ’25 | Mex$2,309.10 | Mex$2,695.87 +16.7% | 14.5% | Mex$3,659.10 | Mex$2,158.87 | n/a | 31 |
Jun ’25 | Mex$1,850.00 | Mex$2,484.56 +34.3% | 15.1% | Mex$3,399.22 | Mex$1,869.57 | n/a | 32 |
May ’25 | Mex$2,320.00 | Mex$2,761.21 +19.0% | 12.3% | Mex$3,404.00 | Mex$2,212.60 | n/a | 33 |
Apr ’25 | Mex$2,217.81 | Mex$2,730.03 +23.1% | 12.2% | Mex$3,363.68 | Mex$2,186.39 | n/a | 33 |
Mar ’25 | Mex$2,335.00 | Mex$2,774.67 +18.8% | 12.1% | Mex$3,410.40 | Mex$2,216.76 | n/a | 33 |
Feb ’25 | n/a | Mex$2,714.21 0% | 15.7% | Mex$3,444.50 | Mex$1,980.59 | n/a | 33 |
Jan ’25 | Mex$2,571.00 | Mex$2,401.48 -6.6% | 19.8% | Mex$3,396.04 | Mex$1,528.22 | n/a | 32 |
Dec ’24 | Mex$2,343.61 | Mex$2,335.01 -0.4% | 19.6% | Mex$3,462.72 | Mex$1,558.22 | n/a | 32 |
Nov ’24 | Mex$1,666.17 | Mex$2,270.62 +36.3% | 19.0% | Mex$3,610.70 | Mex$1,624.82 | n/a | 32 |
Oct ’24 | Mex$1,771.00 | Mex$2,169.88 +22.5% | 19.1% | Mex$3,425.22 | Mex$1,541.35 | Mex$2,879.00 | 30 |
Sep ’24 | Mex$1,856.20 | Mex$2,205.68 +18.8% | 19.8% | Mex$3,409.96 | Mex$1,534.48 | Mex$2,737.20 | 30 |
Aug ’24 | Mex$2,072.59 | Mex$2,212.42 +6.7% | 19.1% | Mex$3,348.88 | Mex$1,507.00 | Mex$2,273.00 | 31 |
Jul ’24 | Mex$1,892.70 | Mex$2,215.83 +17.1% | 20.5% | Mex$3,423.90 | Mex$1,540.76 | Mex$2,309.10 | 30 |
Jun ’24 | Mex$1,734.86 | Mex$2,266.52 +30.6% | 19.3% | Mex$3,097.87 | Mex$1,593.19 | Mex$1,850.00 | 27 |
May ’24 | Mex$1,687.27 | Mex$2,363.92 +40.1% | 17.2% | Mex$3,137.51 | Mex$1,613.57 | Mex$2,320.00 | 27 |
Apr ’24 | Mex$1,744.97 | Mex$2,484.33 +42.4% | 15.7% | Mex$3,228.12 | Mex$1,660.18 | Mex$2,217.81 | 28 |
Mar ’24 | Mex$1,971.12 | Mex$2,480.77 +25.9% | 15.6% | Mex$3,215.82 | Mex$1,837.61 | Mex$2,335.00 | 28 |
Feb ’24 | Mex$2,198.09 | Mex$2,397.00 +9.0% | 20.6% | Mex$3,306.02 | Mex$1,596.66 | n/a | 28 |
Jan ’24 | n/a | Mex$2,550.93 0% | 20.0% | Mex$3,484.34 | Mex$1,682.78 | Mex$2,571.00 | 27 |
Dec ’23 | Mex$2,060.00 | Mex$2,581.81 +25.3% | 20.2% | Mex$3,689.36 | Mex$1,941.77 | Mex$2,343.61 | 26 |
Nov ’23 | Mex$1,887.81 | Mex$2,850.99 +51.0% | 21.9% | Mex$4,279.91 | Mex$1,981.44 | Mex$1,666.17 | 26 |
Oct ’23 | Mex$1,929.00 | Mex$2,909.19 +50.8% | 20.7% | Mex$4,287.06 | Mex$2,163.38 | Mex$1,771.00 | 26 |
Analyst Forecast: Target price is lower than the current share price.